for processing and analyzing multi-channel
recordings of a surface ECG signal are required.
In patients with structural heart diseases
inhomogeneous and delayed electrical activation is
associated with re-entrant and triggered life-
threatening ventricular tachyarrhythmias, as it had
been shown in many scientific researches (Kreiner,
Gottlieb, Furukawa et al., 1992; Wong and Windle,
1994; Teptin, Latfullin, Kоnturov, Mamedova, 2004;
Ohisa, Ohira, Mizonobe et al., 2002). Usually, local
abnormal electrical activation of ventricular
myocardium can be recorded invasively only, when a
mapping catheter is placed at endocardial or
epicardial surface in close proximity to the diseased
area. In clinical practice, invasive mapping of
ventricular tachycardia substrate is aimed at detection
of areas with low amplitude and abnormal local
activity. Although the presence and location of
abnormal activity can be predicted according to
patient clinical characteristics (for instance, in
patients with known localization of post-myocardial
infarction scar), there is a need in prediction models
of the presence and extent of abnormal activity areas
in patients with other cardiac diseases. Pre-procedure
knowledge of localization of the target area for
mapping and further catheter ablation (in order to
terminate and render VTs non-inducibleis of
paramount importance, since it helps to plan the
required access and needed extent of tissue ablation.
The purpose of this study is to develop a
processing algorithm for detecting ventricular late
potentials and fragmented signals from synchronous
recordings of surface ECG and invasively registered
signals, and to improve the accuracy of estimation the
presence of local abnormal electrograms and their
spectral characteristics using the analysis of surface
ECG.
To achieve this goal, we have solved the
following research tasks:
1. Formation of a database of synchronous recordings
of endo- and epicardial electrograms and 12-channel
surface ECG signals reflecting the presence and
absence ventricular late potentials and fragmented
electrograms for various heart rhythm disorders.
2. Detection, analysis and classification of ventricular
late potentials and fragmented QRS complexes using
algorithms for synchronous accumulation and spatial
averaging over surface ECG signals, comparison of
the accuracy of detection of ventricular late and
fragmented potentials and assessment of their
characteristics taking into account synchronous
recordings of intracardiac electrograms.
3. Formation of a complex of indicators of surface
ECG signals correlating with intracardiac ventricular
fragmented and late potentials.
4. Development of an algorithm for identifying late
and fragmented ventricular potentials and evaluating
their temporal, spectral and dynamic characteristics.
5. Formation of a complex of indicators of
fragmented QRS complexes and ventricular late
potentials, reflecting dangerous heart rhythm
disorders.
2 METHODS
2.1
Patient Population
Patients with known structural heart disease and
documented ventricular tachycardia (VT) were
referred for electrophysiological study and catheter
ablation of VT substrate. Inclusion criteria were the
following: the presence of structural myocardial
disease diagnosed using transthoracic
echocardiography, magnetic resonance tomography,
and/or endomyocardial biopsy; VT detected on
surface ECG or by interrogation of an existent cardiac
implantable electronic device (mainly, implantable
cardioverter-defibrillator); signed informed consent
to undergo an invasive electrophysiological study.
Exclusion criteria were the following: the presence of
a reversible VT cause, acute systemic inflammatory
disease, intracardiac thrombosis, the need for
coronary revascularization according to the clinical
and angiographic evaluation.
2.2
Electrophysiological Study
The electrophysiological procedure was performed in
an electrophysiological laboratory; patients were
evaluated in a fasting state under general anesthesia
with propofol, fentanyl and arduan. A femoral access
was performed via the common femoral vein (a
transseptal 8F Multipurpose sheath (Cordis, Johnson
and Johnson, USA) and a 6F vascular sheath (Avanti,
Cordis, Johnson and Johnson, USA) were
introduced), and via the common femoral artery (an
8F vascular sheath was used).
A combined endocardial left ventricular access
was performed retrogradely via the arterial sheath and
using the transseptal access. Puncture of the
interatrial septum was performed using the
Brockenbrough BRK-1 needle (Abbott, USA) with a
small amount of contrast media used to confirm
appropriate access to the left atrium (Optiray 300,
Mallickrodt, Germany).
After successful transseptal puncture the
transseptal sheath was advanced into the left